Sage Products Inc.

About Us

Since 1971, Sage Products has developed innovative healthcare products trusted by healthcare facilities worldwide. Sage has a core belief in prevention—that simple, evidence-based interventions will yield extraordinary outcomes. The company's goal is to help improve patient safety and outcomes by preventing skin breakdown, healthcare-associated pneumonias, surgical site infections and other adverse events. Industry-leading brands include Q•Care® oral care, Sage® 2% Chlorhexidine Gluconate Cloths for patient preoperative skin preparation, Comfort Bath® prepackaged bathing, Comfort Shield® all-in-one incontinence care, Prevalon® pressure-relieving heel protection and the Prevalon® Turn and Position System.

Quotes

Our previous research suggests that NV-VAP is an under-studied and under-reported hospital-acquired infection. The replication study is a national, multisite study seeking to more extensively quantify the potential scope of NV-HAP in all types of hospitals.

Barbara Quinn, MSN, ACNS-BC, RN, clinical nurse specialist

This is an important new area of inquiry for prevention strategies. Our foundation’s role in the study will be to recruit clinicians who have expertise in pneumonia prevention as well as the conduct of research to serve on an oversight committee that will monitor and guide the work of these researchers.

Tejal K. Gandhi, MD, MPH, CPPS, president and CEO of NPSF. “

Pick a time period -

Tags ( Active)

All Regulatory Non-Regulatory

Sage Products Provides Grant to Study Incidence of Pneumonia in Hospitalized Patients

Wed, Feb 11, 2015 10:00 CET

Sage partners with National Patient Safety Foundation (NPSF) to convene expert committee to guide study of non-ventilator associated hospital-acquired pneumonia.Sage Products LLC has partnered with National Patient Safety Foundation (NPSF) to convene an expert committee to guide study of non-ventilator associated hospital-acquired pneumonia (NV-HAP). The study will be conducted in a variety of hospital settings to determine the incidence of NV-HAP in hospitalized patients, a complication that may be under-reported. Ventilator-associated pneumonia (VAP),

New study shows effectiveness of similarly marketed skin barrier products vary based on formulation

Fri, Oct 17, 2014 08:00 CET

Comparison study of incontinence care products containing dimethicone reveals range of barrier effectivenessCARY, IL, October 17, 2014 – Clinicians treating patients suffering from incontinence-associated dermatitis (IAD) often select skin barrier products based on the label or ingredient list—which provides no clear indication of the product’s barrier effectiveness. New research, however, suggests this practice needs to change. The old saying, “don’t judge a book by its cover,” is also true for skin barrier products. “When it comes to choosing skin protectants, there can be a lot of

Court Enters Judgment for Sage Products in Hand Hygiene Patent Infringement Action

Wed, Mar 12, 2014 10:00 CET

CARY, IL, March 12, 2014 – Sage Products LLC (www.sageproducts.com) announced today that the United States District Court for the Northern District of Illinois has entered judgment against SwipeSense, Inc. (“SwipeSense”) in Sage’s lawsuit for patent infringement. In the action, Sage alleged that SwipeSense's Hand Hygiene 2.0 compliance monitoring system and products for hand hygiene infringe upon Sage's United States Patent No. 6,392,546. As part of the judgment, SwipeSense shall not make, use, sell, offer for sale, or import hand hygiene systems that infringe the ’546 patent, including

Sage Products Files Patent Infringement Lawsuit Against SwipeSense

Tue, Nov 05, 2013 01:30 CET

CARY, IL, November 4, 2013 – Sage Products LLC (www.sageproducts.com) announced today that it has filed a lawsuit for patent infringement against SwipeSense, Inc. (“SwipeSense”) in the United States District Court for the Northern District of Illinois. Sage has a proven track record of over forty years for developing innovative products that are shown in published research to reduce surgical site infections, ventilator-associated pneumonia, catheter-associated urinary tract infections and other healthcare-associated infections. In the past few years, Sage has invested heavily in the

Madison Dearborn Partners Completes Acquisition of Sage Products

Thu, Dec 13, 2012 22:31 CET

CARY, ILL. – Dec. 13, 2012 – Madison Dearborn Partners announced today that it has completed its previously announced purchase of Sage Products Inc., a leading healthcare products manufacturer with expected 2012 sales revenues of approximately $290 million. Sage employs more than 700 associates and maintains a portfolio that includes innovative infection prevention and patient safety products for the entire healthcare continuum. Sage’s existing management team will continue to own a significant portion of the company. Sage will continue to operate under the same name while providing

There are no items matching the current filter

There are no more items matching the current filter

Share